There are conflicting reports about the association of endothelial nitric oxide synthase (eNOS) gene polymorphism and the risk of coronary artery disease (CAD). To determine the frequency of eNOS G894T variant and to find the possible association between this polymorphism with CAD we studied 207 unrelated patients with total CAD (with and without diabetes) and 92 controls. The eNOS variants were detected by polymerase chain reaction–restriction fragment length polymorphism (PCR-RFLP). The presence of GT + TT genotype was associated with 2.1-fold (P = .006), 2.29-fold (P = .006), and 1.93-fold (P = .032) increased risk of CAD in total CAD, CAD with diabetes, and in CAD without diabetes patients, respectively. The presence of T allele of eNOS increased the risk of CAD 2.15-fold (P = .001). The levels of low-density lipoprotein cholesterol (LDL-C) and triglycerides (TG) tended to be higher in patients carrier for T allele compared to those with G allele. The results of present study revealed that eNOS G894T polymorphism is associated with increased risk of CAD in our population.
HatmiZNTahvildariSGafarzadeh MotlagASabouri KashaniA.Prevalence of coronary artery disease risk factors in Iran: a population based survey. BMC Cardivasc Dis. 2007;7:32.
2.
Vaisi-RayganiARahimiZNomaniHTavilaniHPourmotabbedT.The presence of apolipoprotein ϵ4 and ϵ2 alleles augments the risk of coronary artery disease in type 2 diabetic patients. Clin Biochem. 2007;40(15):1150–1156.
3.
ZintzarasEPapathanasiouAAStefanidisI.Endothelial nitric oxide synthase gene polymorphisms and diabetic nephropathy: a HuGE review and meta-analysis. Genet Med. 2009;11(10):695–706.
4.
MiyamotoYSaitoYKajiyamaN. Endothelial nitric oxide synthase gene is positively associated with essential hypertension. Hypertension. 1998;32(1):3–8.
5.
ColomboMGAndreassiMGParadossiU. Evidence for association of a common variant of the endothelial nitric oxide synthase gene (Glu298Asp polymorphism) to the presence, extent and severity of coronary artery disease. Heart. 2002;87(6):525–528.
6.
ZhangCLopez-RidauraRHunterDJRifaiNHuFB.Common variants of the endothelial nitric oxide synthase gene and the risk of coronary heart disease among U.S. diabetic men. Diabetes. 2006;55(7):2140–2147.
7.
TesauroMThompsonWCRoglianiPQiLChaudharyPPMossJ.Intracellular processing of endothelial nitric oxide synthase isoforms associated with differences in severity of cardiopulmonary diseases: cleavage of proteins with aspartate vs. glutamate at position 298. Proc Natl Acad Sci U S A. 2000;97(6):2832–2835.
8.
HingoraniADLiangCFFatibeneJ. A common variant of the endothelial nitric oxide synthase (Glu298Asp) is a major risk factor for coronary artery disease in the UK. Circulation. 1999;100(14):1515–1520.
9.
ShimasakiYYasueHYoshimuraM. Association of the missense Glu298Asp variant of the endothelial nitric oxide synthase gene with myocardial infarction. J Am Coll Cardiol. 1998;31(7):1506–1510.
10.
TamemotoHIshikawaSKawakamiM.Association of the Glu298Asp polymorphism of the eNOS gene with ischemic heart disease in Japanese diabetic subjects. Diabetes Res Clin Pract. 2008;80(2):275–279.
11.
LinNTLeeMJLeeRPHongATChenHI.Analysis of endothelial nitric oxide synthase gene polymorphisms with cardiovascular disease in eastern Taiwan. Chin J Physiol. 2008;51(1):42–47.
12.
CamSFSekuriCTengizI. The G894T polymorphism on endothelial nitric oxide synthase gene is associated with premature coronary artery disease in a Turkish population. Thrombosis Res. 2005;116(4):287–292.
13.
BerdeliASekuriCSirri CamF. Association between the eNOS (Glu298Asp) and the RAS genes polymorphisms and premature coronary artery disease in a Turkish population. Clin Chim Acta. 2005;351(1-2):87–94.
14.
KerkeniMAddadFChauffertM. Hyperhomocysteinemia, endothelial nitric oxide synthase polymorphism, and risk of coronary artery disease. Clin Chem. 2006;52(1):53–58.
15.
MotawiTShakerOTahaMSedrakHNabilM.Endothelial nitric oxide synthase and angiotensinogen gene polymorphism in coronary artery diseases in Egypt. Angiology. 2011;62(2):191–197.
16.
SzaboGVKunstarAAcsadyG.Methylenetetrahydrofolate reductase and nitric oxide synthase polymorphism in patients with atherosclerosis and diabetes. Pathol Oncol Res. 2009;15(4):631–637.
17.
BrscicEBergeroneSGagnorA. Acute myocardial infarction in young adults: prognostic role of angiotensin-converting enzyme, angiotensin II type I receptor, apolipoprotein E, endothelial constitutive nitric oxide synthase, and glycoprotein IIIa genetic polymorphisms at medium-term follow-up. Am Heart J. 2000;139(6):979–984.
18.
CaiHWilckenDEWangXL.The Glu298Asp (894G→T) mutation at exon 7 of the endothelial nitric oxide synthase gene and coronary artery disease. J Mol Med. 1999;77(6):511–514.
19.
LiyouNSimonsLFriedlanderY. Coronary artery disease is not associated with the E298D variant of the constitutive, endothelial nitric oxide synthase gene. Clin Genet. 1998;54(6):528–529.
20.
JaramilloPCLanasCLanasFSalazarLA.Polymorphisms of the NOS3 gene in Southern Chilean subjects with coronary artery disease and controls. Clin Chim Acta. 2010;411(3-4):258–262.
21.
KimIJBaeJLimSW. Influence of endothelial nitric oxide synthase gene polymorphisms (-786T→C, 4a4b, 894G→T) in Korean patients with coronary artery disease. Thrombosis Res. 2007;119(5):579–585.
22.
MathewJNarayananPSundaramR. Lack of association between Glu (298) Asp polymorphism of endothelial nitric oxide synthase (eNOS) gene and coronary artery disease in Tamilian population. Indian Heart J. 2008;60(3):223–227.
23.
NasserBABevinLDJohnstoneDE. Relationship of the Glu298Asp polymorphism of the endothelial nitric oxide synthase gene and early-onset coronary artery disease. Am Heart J. 2001;142(4):586–589.
24.
ArasOHansonNQBakanaySMTsaiMYGulecS.Endothelial nitric oxide gene polymorphism (Glu298Asp) is not associated with coronary artery disease in Turkish population. Thromb Haemost. 2002;87(2):347–349.
25.
AndrikopoulosGKGrammatopoulosDKTzeisSE. Association of the 894G→T polymorphism in the endothelial nitric oxide synthase gene with risk of acute myocardial infarction. BMC Med Genet. 2008;9:43.
26.
JafariYRahimiZVaisi-RayganiARezaeiM.Interaction of eNOS polymorphism with MTHFR variants increase the risk of diabetic nephropathy and its progression in type 2 diabetes mellitus patients. Mol Cell Biochem. 2011;353(1-2):23-34;
27.
JudkinsMP. Selective coronary arteriography. I. A percutaneous transfemoral technique. Radiology. 1967;89(5):815–824.
28.
WHO Study Group Report of a WHO consultation. Part 1. Diagnosis and Classification of Diabetes Mellitus. Geneva:World Health Organization; 1999.
29.
OldJMHiggsDR.Gene analysis. In:WeatherallDJ (Ed.), Methods in Hemotology. Vol 6. The thalassemias. Livingstone; 1983: 74–101.
30.
ZintzarasELauJ.Synthesis of genetic association studies for pertinent gene-disease associations requires appropriate methodological and statistical approaches. J Clin Epidemiol. 2008;61(7):634–645.
CasasJPBautistaLEHumphriesSEHingoraniA.Endothelial nitric oxide synthase genotype and ischemic heart disease. Meta-analysis of 26 studies involving 23028 subjects. Circulation. 2004;109(11):1359–1365.
33.
LiJWuXLiXFengGHeLShiY.The endothelial nitric oxide synthase gene is associated with coronary artery disease: a meta-analysis. Cardiology. 2010;116(4):271–278.
34.
GulecSKarabulutHOzdemirAO. Glu298Asp polymorphism of the eNOS is associated with coronary collateral development. Atherosclerosis. 2008;198(2):354–359.
35.
OdebergJLarssonCARastamLLindbladU.The Asp298 allele of endothelial nitric oxide synthase is a risk factor for myocardial infarction among patients with type 2 diabetes mellitus. BMC Cardiovasc Dis. 2008;8:36.
36.
DrewBGFidgeNHGallon-BeaumierGKempBEKingwellBA.High-density lipoprotein and apolipoprotein AI increase endothelial NO synthase activity by protein association and multisite phosphorylation. Proc Natl Acad Sci USA. 2004;101(18):6999–7004.
37.
NoferJRvan der GietMToelleM. HDL induces NO dependent vasorelaxation via the lysophospholipid receptor S1P3. J Clin Invest. 2004;113(4):569–581.
38.
KarvonenJKaumaHKervinenK. Endothelial nitric oxide synthase gene Glu298Asp polymorphism and blood pressure, left ventricular mass and carotide artery atherosclerosis in a population-based cohort. J Intern Med. 2002;251(2):102–110.
39.
Nagib El-KilanyGENayelEHazzaaS.Nitric oxide synthase gene G298 allele is it a marker for microvascular angina in hypertensive patients?Cardiovasc Radiation Med. 2004;5(3):113–118.
40.
WangCLHsuLAKoYSKoYLLeeYH.Lack of association between the Glu298Asp variant of the endothelial nitric oxide synthase gene and the risk of coronary artery disease among Taiwanese. J Formos Med Assoc. 2001;100(11):736–740.
41.
GlubaABanachMRyszJPiotrowskiGFendlerWPietruchaT.Is polymorphism within eNOS gene associated with the late onset of myocardial infarction? A pilot study. Angiology. 2009;60(5):588–595.
42.
PereiraACSpositoACMotaGF. Endothelial nitric oxide synthase gene variant modulates the relationship between serum cholesterol levels and blood pressure in the general population: new evidence for a direct effect of lipids in arterial blood pressure. Atherosclerosis. 2006;184(1):193–200.
